Bupe for adolescents and young adults: Recommendations based on data

Bupe for adolescents and young adults: Recommendations based on data Bottom Line…Researchers summarize the limited but positive data showing that buprenorphine is an appropriate treatment for adolescents and young adults with opioid use disorders, and discuss dosing and psychosocial treatment protocols.Few adolescents and young adults with opioid use disorders (OUDs) can access treatment, even though medications and psychosocial services are available, researchers wrote in the current issue of the Journal of Addiction Medicine.There have been three randomized controlled trials (RCTs) (see ADAW, Oct. 10, 2005, Nov. 10, 2008, and Oct. 24, 2016), as well as many observational studies, showing the effectiveness of buprenorphine treatment for young people, but until now, they have not been summarized. Based on their summary, the researchers encourage treatment with buprenorphine for adolescents and young adults.Many adolescents and young adults are transitioning from abuse of prescription opioids to heroin, a trend that has made the need for treatment all the more urgent, the researchers wrote. Methadone and buprenorphine are effective components of standard treatment for adults with OUDs. They reduce risk of death, and improve abstinence and treatment retention. A large body of literature supports maintenance treatment.But for adolescents, access to buprenorphine — which unlike methadone does not require daily clinic visits — is restricted. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alcoholism and Drug Abuse Weekly Wiley

Bupe for adolescents and young adults: Recommendations based on data

Loading next page...
 
/lp/wiley/bupe-for-adolescents-and-young-adults-recommendations-based-on-data-s2xQPx0l6f
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Wiley Periodicals, Inc., A Wiley Company
ISSN
1042-1394
eISSN
1556-7591
D.O.I.
10.1002/adaw.31890
Publisher site
See Article on Publisher Site

Abstract

Bottom Line…Researchers summarize the limited but positive data showing that buprenorphine is an appropriate treatment for adolescents and young adults with opioid use disorders, and discuss dosing and psychosocial treatment protocols.Few adolescents and young adults with opioid use disorders (OUDs) can access treatment, even though medications and psychosocial services are available, researchers wrote in the current issue of the Journal of Addiction Medicine.There have been three randomized controlled trials (RCTs) (see ADAW, Oct. 10, 2005, Nov. 10, 2008, and Oct. 24, 2016), as well as many observational studies, showing the effectiveness of buprenorphine treatment for young people, but until now, they have not been summarized. Based on their summary, the researchers encourage treatment with buprenorphine for adolescents and young adults.Many adolescents and young adults are transitioning from abuse of prescription opioids to heroin, a trend that has made the need for treatment all the more urgent, the researchers wrote. Methadone and buprenorphine are effective components of standard treatment for adults with OUDs. They reduce risk of death, and improve abstinence and treatment retention. A large body of literature supports maintenance treatment.But for adolescents, access to buprenorphine — which unlike methadone does not require daily clinic visits — is restricted.

Journal

Alcoholism and Drug Abuse WeeklyWiley

Published: Jan 12, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off